Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-015318
Filing Date
2025-02-19
Accepted
2025-02-19 21:44:28
Documents
2
Period of Report
2025-02-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm257103-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm257103-2_4seq1.xml 4 6836
2 EXHIBIT 24 tm257103d2_ex24.htm EX-24 6094
  Complete submission text file 0001104659-25-015318.txt   14525
Mailing Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Issuer) CIK: 0001649904 (see all company filings)

EIN.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O RHYTHM PHARMACEUTICALS 222 BERKELEY STREET, SUITE 1200 BOSTON MA 02116
Business Address
Garfield Alastair (Reporting) CIK: 0002027261 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38223 | Film No.: 25643020